Yizhen Xu
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research 2
-
- Statistical Methods and Inference 2
- Statistical Methods and Bayesian Inference 1
-
- HIV/AIDS Research and Interventions 2
- SARS-CoV-2 and COVID-19 Research 1
-
- HIV Research and Treatment 1
-
- Extracellular vesicles in disease 1
-
- Respiratory viral infections research 1
- Co-authors
- Robert C. StantonBrent W. OsborneLawrence BlondeCheng‐Tao ChangJohn B. BuseGiorgio SestiEduard MontanyaWolfgang E. Schmidt
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)Current Opinion in Critical Care (1 paper)Journal of Computational and Graphical Statistics (1 paper)
- Partner nations
- United StatesChinaKenya
In The Last Decade
Yizhen Xu
11 papers receiving 462 citations
Peers
Comparison fields: 5 of 82
- Endocrinology, Diabetes and Metabolism 248
- Clinical Biochemistry 46
- Nephrology 25
- Physiology 84
- Pharmacology 52
Countries citing papers authored by Yizhen Xu
This map shows the geographic impact of Yizhen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yizhen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yizhen Xu more than expected).
Fields of papers citing papers by Yizhen Xu
This network shows the impact of papers produced by Yizhen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yizhen Xu. The network helps show where Yizhen Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yizhen Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 8 | |
| 9 | 2019 | 0 | |
| 10 | 2017 | 5 | |
| 11 | 2010 | 148 | |
| 12 | 2009 | 77 | |
| 13 | 2009 | 18 | |
| 14 | 2005 | 172 | |
| 15 | 2005 | 44 |
About Yizhen Xu
Yizhen Xu is a scholar working on Clinical Biochemistry, Statistics and Probability and Infectious Diseases, having authored 15 papers that have together received 492 indexed citations. Recurring topics across this work include Statistical Methods and Inference (2 papers), HIV/AIDS Research and Interventions (2 papers), Advanced Glycation End Products research (2 papers), Statistical Methods and Bayesian Inference (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), HIV Research and Treatment (1 paper), Extracellular vesicles in disease (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (248 citations), Clinical Biochemistry (46 citations) and Nephrology (25 citations). Yizhen Xu has collaborated with scholars based in United States, China and Kenya. Frequent co-authors include Robert C. Stanton, Brent W. Osborne, Lawrence Blonde, Cheng‐Tao Chang, John B. Buse, Giorgio Sesti, Eduard Montanya, Wolfgang E. Schmidt, Julio Rosenstock and Zhiheng He. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Current Opinion in Critical Care, Journal of Computational and Graphical Statistics, American Journal of Physiology-Renal Physiology and Computers & Security.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.